Logo

Pairings: Sep 21, 2011

Sep 22, 2011
Premium

CardioDx has hired Andrew Guggenhime as its new chief financial officer and Mark Monane as its chief medical officer.

Guggenhime has more than decade of experience as a CFO for various firms. Most recently, he served as CFO for Gilead Sciences subsidiary Calistoga Pharmaceuticals.

Monane was managing director of equity research for Needham & Company for 11 years, and before that he was senior director of medical policy and practices at Medco Health Solutions.

Filed under

Diagnostics
CardioDx
Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.